In the evolving landscape of biomedical innovation, exosomes have emerged as one of the most promising tools for next-generation therapies. These nanoscale, membrane-bound vesicles, naturally secreted by cells, play a critical role in intercellular communication. Because of their inherent ability to shuttle biomolecules like RNA, proteins, and lipids between cells, exosomes have captivated the attention of researchers and biotech companies for their vast potential in therapeutic applications. [Read more…]
Exosome Research: Who Is Dominating in the Scientific Literature?
Exosome research is experiencing rapid growth, driven by the increasing recognition of their critical role in intercellular communication and molecular transport. These extracellular vesicles act as natural carriers of proteins, lipids, and genetic material, influencing a wide range of physiological and pathological processes. As a result, they are emerging as a promising tool in regenerative medicine, drug delivery, and disease diagnostics.
Beyond their biological significance, exosomes are attracting attention for their potential therapeutic applications. Because they can mediate many of the beneficial effects traditionally associated with cells—without the same risks of immune rejection or uncontrolled proliferation—they are increasingly attracting attention and investment. [Read more…]
Dr. Askenase on the Role of MSC-Derived Exosomes in Healing the Injured Spinal Cord
This interview features Dr. Philip Askenase, MD, a Professor of Medicine and Pathology at Yale University School of Medicine. A leading expert in the effector properties of exosomes, Dr. Askenase is now delving into the regenerative potential of mesenchymal stem cell (MSC)-derived exosomes.
His latest, as-yet-unpublished research focuses on using MSC-derived exosomes to promote healing in injured spinal cords in rats. In our conversation, we examine the expanding significance of MSC-derived exosomes, their unique advantages, and diverse applications. We also discuss the market opportunities for stem cell exosomes and the companies driving innovation in this emerging field.
Funding Flows Freely into Exosome Therapeutics in 2025
The therapeutic applications of exosomes, particularly those derived from stem cells and cancer cells, continue to expand in 2025, driving accelerated innovation in this dynamic market. Emerging trends highlight the potential of exosomes as both diagnostic tools and cell-free therapeutics, with increasing applications across diverse fields such as oncology, neurology, and regenerative medicine. In parallel, a growing number of life science companies are providing advanced tools and reagents to support exosome research, reflecting the sector’s rapid growth. [Read more…]
The Booming Market for Exosomes in 2025
Exosome-related technologies have been developing rapidly over the past few years and substantial growth is expected for the market as they get integrated into the fields of liquid biopsy, precision medicine and regenerative medicine. In particular, cancer derived exosomes influence the invasive potential of cells by regulating angiogenesis, metastasis, and immunity, making them an extremely useful source of biomarkers for use in cancer detection, diagnosis, and therapeutic selection. [Read more…]
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 27
- Next Page »